Osseodensification and Dental Implant Stability

Sponsor
University of Dublin, Trinity College (Other)
Overall Status
Recruiting
CT.gov ID
NCT05376020
Collaborator
(none)
46
1
2
24
1.9

Study Details

Study Description

Brief Summary

Osseointegration refers to the formation of a structural and functional bone-to-implant interface, without the interposition of soft tissue. Successful osseointegration will provide long term success for the dental implant. Primary implant stability, is the mechanical stability between bone and the implant at the time of insertion and is key to initiate a successful osseointegration.

Both primary implant stability and osseointegration are affected by the density of the bone where the implant is placed. A relatively new technique known as osseodensification (OD) has been developed and uses specially designed burs (Densah burs). Compared to conventional drills (CD) that remove bone (subtractive drilling) these burs are designed so that they can rotate in a counterclockwise (CCW) (non subtractive) direction which allows bone to be preserved and compacted into the wall of the osteotomy site. These drills therefore theoretically maintain bone volume which then creates higher bone density and bone to implant contact allowing better implant primary stability.

This study will be a randomised control trial comparing OD to CD with regards to implant stability and bone levels. Considering the increased cost of OD, available literature must support a significant clinical benefit of OD over CD to consider them for clinical use. This study will aim to reinforce available clinical research and address some of the limitations of the current evidence to aid clinicians in making an evidenced-based decision on the use of OD when poor bone density could compromise implant success.

Condition or Disease Intervention/Treatment Phase
  • Device: Densah Burs
  • Device: Conventional Burs
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Randomised Control Clinical Trial Investigating the Effect of Osseodensification on Implant Stability and Marginal Bone Levels
Anticipated Study Start Date :
May 13, 2022
Anticipated Primary Completion Date :
May 13, 2024
Anticipated Study Completion Date :
May 13, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Densah Burs

Intervention Group

Device: Densah Burs
Densah Burs will be used in the intervention group

Active Comparator: Conventional Burs

Control Group

Device: Conventional Burs
Conventional Burs will be used in the control group

Outcome Measures

Primary Outcome Measures

  1. Implant Stability [During procedure (implant placement)]

    Implant stability Quotient (ISQ) will be measured using magnetic resonance frequency analysis (MRFA) - the device is called OSSTELL. A transducer is attached to the implant and brought to vibration by magnetic pulses from the probe of the Osstell device which makes the implant vibrate. The implant's resistance to vibration is expressed as the ISQ value. High vibration frequency signifies high implant stability.

  2. Implant Stability [At time of second stage implant surgery (3 months)]

    Implant stability Quotient (ISQ) will be measured using magnetic resonance frequency analysis (MRFA) - the device is called OSSTELL. A transducer is attached to the implant and brought to vibration by magnetic pulses from the probe of the Osstell device which makes the implant vibrate. The implant's resistance to vibration is expressed as the ISQ value. High vibration frequency signifies high implant stability.

  3. Implant Stability [At implant restoration (5 months)]

    Implant stability Quotient (ISQ) will be measured using magnetic resonance frequency analysis (MRFA) - the device is called OSSTELL. A transducer is attached to the implant and brought to vibration by magnetic pulses from the probe of the Osstell device which makes the implant vibrate. The implant's resistance to vibration is expressed as the ISQ value. High vibration frequency signifies high implant stability.

Secondary Outcome Measures

  1. Insertion torque [During procedure (implant placement)]

    Insertion torque of implant will be measured using standard torque wrench

  2. Marginal bone levels [During procedure (implant placement)]

    Will be measured clinically using a periodontal probe and radiographically

  3. Marginal bone levels [At time of second stage implant surgery (3 months)]

    Will be measured clinically using a periodontal probe

  4. Marginal bone levels [At implant restoration (5 months)]

    Will be measured clinically using a periodontal probe and radiographically

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Patient Level

  • Male or Female, 18 years old or over

  • Capacity to provide informed consent

  • Willing to comply with study appointment schedule Willing to maintain a diary of symptoms

  • Planned for provision of dental implant(s) at Dublin Dental University Hospital

Site Level

  • Location: maxilla

  • Sufficient bone volume for implant placement without the need for bone graft/augmentation; alveolar ridge of minimum 6mm width for standard implants (implant diameter 4mm) and of minimum 7mm for wider implants (implant diameter 5mm)

Exclusion Criteria:

Patient Level

  • Plaque score >20%

  • Bleeding score >20%

  • Tobacco smoking

  • Uncontrolled systemic disease

  • Use of systemic medications with an expected impact on bone healing (e.g. bisphosphonates)

  • Pregnancy or lactation

  • Lack of capacity to give an informed consent

Site Level

  • Location: mandible

  • Insufficient bone volume for implant placement, requiring bone graft/augmentation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dublin Dental Hospital/Trinity College Dublin Dublin Ireland

Sponsors and Collaborators

  • University of Dublin, Trinity College

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ioanna Politi, Principal Investigator, University of Dublin, Trinity College
ClinicalTrials.gov Identifier:
NCT05376020
Other Study ID Numbers:
  • IPoliti
First Posted:
May 17, 2022
Last Update Posted:
May 17, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 17, 2022